Post-stroke spasticity is associated with restriction in the range of motion of the shoulder. Reducing muscular dystrophy may help relieve muscular dysfunction
Chondroitin sulfate proteoglycan-4 (CSPG4) is a surface component of two key cell types (oligoden-drocyte progenitor cells (OPCs) and myeloid cells) present in